<div>
<p>Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. 	For the Beacon Tactical Risk ETF (Symbol: BTR), we found that the implied analyst target price for the ETF based upon its underlying holdings is $29.77 per unit.</p><p>With BTR trading at a recent price near $27.16 per unit, that means that analysts see 9.61% upside for this ETF looking through to the average analyst targets of the underlying holdings.   Three of BTR's underlying holdings with notable upside to their analyst target prices are Vanguard Sector Index Funds Vanguard Health Care ETF (Symbol: VHT), Vanguard Sector Index Funds Vanguard Materials ETF (Symbol: VAW), and Vanguard Sector Index Funds Vanguard Information Technology ETF (Symbol: VGT). Although VHT has traded at a recent price of $274.04/share, the average analyst target is 16.77% higher at $0.00/share. Similarly, VAW has 15.53% upside from the recent share price of $221.39 if the average analyst target price of $0.00/share is reached, and analysts on average are expecting VGT to reach a target price of $128.45/share, which is 15.18% above the recent price of $111.52. Below is a twelve month price history chart comparing the stock performance of VHT, VAW, and VGT:  

</p><p><img alt="VHT, VAW, and VGT Relative Performance Chart" src="https://imageproxy.pbkrs.com/https://secure.tickertech.com/pics/2026/679069183A1.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://secure.tickertech.com/pics/2026/679069183A1.gif"/>
</p><p>Combined, VHT, VAW, and VGT represent 28.37% of the Beacon Tactical Risk ETF. Below is a summary table of the current analyst target prices discussed above:

</p><p></p><section><table><tbody><tr> <th>Name</th> <th align="center">Symbol</th> <th align="right">Recent Price</th> <th align="right">Avg. Analyst 12-Mo. Target</th> <th align="right">% Upside to Target</th></tr><tr> <td><b>Beacon Tactical Risk ETF</b></td> <td align="center"><b>BTR</b></td> <td align="right"><b>$27.16</b></td> <td align="right"><b>$29.77</b></td> <td align="right"><b>9.61%</b></td></tr><tr> <td>Vanguard Sector Index Funds Vanguard Health Care ETF</td> <td align="center">VHT</td> <td align="right">$274.04</td> <td align="right">$0.00</td> <td align="right">16.77%</td></tr><tr> <td>Vanguard Sector Index Funds Vanguard Materials ETF</td> <td align="center">VAW</td> <td align="right">$221.39</td> <td align="right">$0.00</td> <td align="right">15.53%</td></tr><tr> <td>Vanguard Sector Index Funds Vanguard Information Technology ETF</td> <td align="center">VGT</td> <td align="right">$111.52</td> <td align="right">$128.45</td> <td align="right">15.18%</td></tr></tbody></table></section><p>Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.  

</p><p>
<img height="16" src="https://imageproxy.pbkrs.com/https://www.dividendchannel.com/nslideshow.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="16" original-src="https://imageproxy.pbkrs.com/https://www.dividendchannel.com/nslideshow.gif"/> 10 ETFs With Most Upside To Analyst Targets »
</p><p>
</p><h5>Also see:</h5><p>
	 Defense Dividend Stocks<br/>
	 Institutional Holders of GBS<br/>
	 Top Stocks Held By Ken Griffin<br/>
</p>
<p>The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.</p>
</div>

<p>Analysts project a 9.61% upside for the Beacon Tactical Risk ETF (BTR), with an implied target price of $29.77 compared to its recent trading price of $27.16. Notable underlying holdings include Vanguard Health Care ETF (VHT) with a 16.77% upside, Vanguard Materials ETF (VAW) at 15.53%, and Vanguard Information Technology ETF (VGT) at 15.18%. Investors are encouraged to assess whether analysts' targets are justified or overly optimistic.</p>

nasdaq

VG Info Tech

Beacon Tactical Risk ETF

Analysts Anticipate 10% Upside For BTR